Multiple Myeloma
Showing NaN - NaN of 79
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
-
Tucson, Arizona
- +163 more
Feb 25, 2022
Presentation, Treatment Patterns, and Outcomes in Multiple
Completed
- Multiple Myeloma
- No Intervention
-
Little Rock, Arkansas
- +136 more
Feb 15, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)
Completed
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- Dexamethasone
-
Whittier, California
- +19 more
Feb 2, 2022
Multiple Myeloma Trial in Spain (Clarithromycin, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Clarithromycin
- +2 more
-
A Coruña, Spain
- +25 more
Jan 17, 2022
Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Graz, Austria
- +111 more
Dec 10, 2021
Multiple Myeloma Trial in Spain (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +4 more
-
Sevilla, Andalucia, Spain
- +17 more
Dec 3, 2021
Biological Relapse in Patients With Multiple Myeloma
Terminated
- Multiple Myeloma
-
Zaragoza, Aragón, Spain
- +43 more
Sep 7, 2021
Multiple Myeloma Trial in Worldwide (Pomalidomide and Dexamethasone)
Completed
- Multiple Myeloma
- Pomalidomide and Dexamethasone
-
Linz, Austria
- +21 more
Aug 25, 2021
Assess Disease Burden, in Terms of Health-related Quality of
Active, not recruiting
- Multiple Myeloma
-
Algeciras, Andalusia, Spain
- +64 more
Aug 18, 2021
Treatment in Relapsed Multiple Myeloma and Creatinine Clearance
Completed
- Multiple Myeloma
- Anti-myeloma treatment at physician discretion
-
Jaen, Andalucia, Spain
- +39 more
Aug 12, 2021
Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Durvalumab
- +2 more
-
Little Rock, Arkansas
- +34 more
Aug 4, 2021
Multiple Myeloma, Renal Insufficiency Trial in Spain, United Kingdom, United States (BHQ880, BHQ880 Placebo, bortezomib)
Completed
- Multiple Myeloma
- Renal Insufficiency
- BHQ880
- +3 more
-
Chicago, Illinois
- +7 more
Dec 11, 2020
Multiple Myeloma Symptomatic Relapse and/or Refractory Disease
Completed
- Multiple Myeloma
- No Intervention
-
Cadiz, Andalucia, Spain
- +29 more
Sep 14, 2020
Multiple Myeloma Trial in Spain (zoledronic acid, No treatment control)
Completed
- Multiple Myeloma
- zoledronic acid
- No treatment control
-
Badalona, Spain
- +15 more
Apr 3, 2020
Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for
Completed
- Multiple Myeloma
- Lenalidomide and low-dose dexamethasone
- +2 more
-
Birmingham, Alabama
- +287 more
Nov 7, 2019